rift
valley
fever
rvf
mosquitoborn
zoonot
diseas
among
human
rumin
caus
rift
valley
fever
viru
rvfv
belong
famili
bunyavirida
genu
phleboviru
rvf
endem
subsaharan
african
countri
caus
major
outbreak
sever
countri
includ
kenya
tanzania
somalia
south
africa
madagascar
egypt
sudan
mauritania
seneg
saudi
arabia
yemen
pregnant
rumin
infect
rvfv
typic
subject
highrat
abort
fetal
malform
subclinicaltofat
febril
ill
newborn
lamb
usual
die
acut
hepat
rvfv
infect
human
primarili
caus
selflimit
febril
ill
howev
patient
develop
hemorrhag
fever
neurolog
disord
blind
febril
period
endem
area
floodwat
aed
mosquito
aemcintoshi
aevexan
serv
vector
viru
could
transmit
offspr
transovari
heavi
rainfal
flood
river
bank
due
construct
dam
increas
number
perman
fresh
water
speci
mosquito
culex
pipen
play
role
amplifi
rvfv
among
mosquito
rumin
human
outbreak
rvf
develop
countri
eg
us
europ
could
forc
curtail
livestock
movement
prevent
rvfv
spread
caus
massiv
econom
loss
substanti
degre
panic
societi
bodi
fluid
infect
anim
contain
infecti
rvfv
mosquito
culex
spp
aed
spp
anophel
spp
might
spread
rvfv
mosquito
human
anim
effect
vaccin
antivir
drug
necessari
contain
outbreak
treatment
rvf
patient
respect
howev
neither
safe
effect
vaccin
effici
treatment
avail
correct
understand
rvf
pathogenesi
essenti
develop
effect
vaccin
antivir
drug
rvf
review
describ
clinic
patholog
find
rvf
human
anim
discuss
viral
host
factor
affect
rvf
pathogenesi
mani
rvfv
laboratori
infect
occur
due
lack
appropri
biosafeti
procedur
howev
patient
later
outbreak
suffer
selflimit
nonfat
ill
typic
incub
period
rvf
day
symptom
start
abruptli
sever
chill
malais
dizzi
weak
sever
headach
nausea
andor
sensat
full
liver
region
symptom
follow
elev
bodi
temperatur
decreas
blood
pressur
pain
back
shoulder
neck
leg
rigor
shiver
flush
face
red
eye
sore
constip
insomnia
andor
photophobia
occasion
symptom
seen
includ
epistaxi
abdomin
pain
lack
gustatori
discrimin
vomit
andor
diarrhea
lessen
symptom
observ
day
bodi
temperatur
often
decreas
normal
level
day
onset
symptom
howev
within
day
recoveri
bodi
temperatur
patient
experi
tempor
recurr
high
fever
sever
headach
day
moreov
patient
may
longlast
high
fever
much
day
bodi
temperatur
becom
normal
patient
may
develop
massiv
coronari
thrombosi
persist
ach
leg
two
week
persist
abdomin
discomfort
week
palpabl
enlarg
liver
spleen
common
convalesc
phase
patient
often
experi
weak
malais
tendenc
sweat
frequent
headach
pain
motion
eye
sens
imbal
viru
demonstr
blood
febril
period
day
wherea
neutral
antibodi
also
start
appear
around
day
onset
symptom
maar
et
al
describ
case
enceph
rvf
patient
patient
exhibit
symptom
sudden
fever
rigor
retroorbit
headach
two
day
fever
day
onset
ill
experienc
neck
rigid
last
five
day
day
subsequ
sometim
confus
otherwis
mental
affect
experienc
tempor
vision
loss
without
detect
retinopathi
also
exhibit
convuls
attack
hyperflexia
fever
day
serum
contain
antirvfv
hemagglutin
hai
antibodi
day
day
cerebrospin
fluid
csf
contain
hai
antibodi
day
day
csf
also
contain
increas
number
white
blood
cell
consist
mainli
lymphocyt
day
indic
possibl
occurr
viral
mening
meningoenceph
patient
recov
treatment
amantadin
rifampicin
dexamethason
two
week
although
effect
therapi
could
evalu
precis
anoth
case
enceph
retin
describ
alrajhi
et
al
patient
fever
atax
gait
bilater
retin
hemorrhag
could
count
finger
csf
contain
mani
leukocyt
includ
lymphocyt
conscious
level
decreas
discharg
day
ill
home
time
awak
blind
quadreparet
incontin
moreov
neurolog
condit
improv
next
year
addit
report
describ
patient
persist
hemiparesi
four
month
onset
ill
anoth
paper
report
rvf
patient
develop
neurolog
sign
symptom
includ
mening
irrit
confus
stupor
coma
hypersaliv
teethgrind
visual
hallucin
lockedin
syndrom
choreiform
movement
upper
limb
patient
histopatholog
lesion
brain
character
focal
necros
associ
infiltr
round
cell
mostli
lymphocyt
macrophag
perivascular
cuf
patient
suffer
maculopathi
retinopathi
patient
notic
loss
central
vision
blur
eye
occur
variou
time
infect
eg
immedi
diseas
onset
sever
week
month
later
one
eye
could
affect
affect
eye
macular
edema
exud
contain
white
mass
cover
macular
area
without
retin
hemorrhag
vascul
infarct
vitreou
haze
addit
retin
detach
uveiti
arteri
occlus
report
patient
mani
case
complet
recoveri
vision
occur
chorioretin
scar
remain
macular
paramacular
area
spite
resorpt
exud
patient
show
partial
improv
vision
sever
month
rvfv
infect
fatal
rvf
case
often
involv
hemorrhag
manifest
time
death
vari
among
case
typic
ill
start
suddenli
patient
experi
fever
rigor
nausea
vomit
headach
inject
conjunct
drowsi
andor
bodi
pain
patient
may
also
symptom
macular
rash
entir
trunk
ecchymos
arm
limb
andor
eyelid
bleed
gum
andor
gastrointestin
mucos
membran
low
blood
pressur
hematemesi
melena
diarrhea
throat
pain
pneumon
jaundic
andor
hepatosplenomegali
typic
elev
alanin
aminotransferas
alt
aspart
aminotransferas
ast
lactat
dehydrogenas
ldh
reduct
platelet
count
hemoglobin
seen
patient
mani
case
death
occur
day
patient
becom
symptomat
howev
case
death
occur
day
onset
symptom
postmortem
examin
show
diffus
necrosi
hepatocyt
greatli
affect
centrilobular
area
portal
area
may
indic
associ
acut
hepat
injuri
type
pathogenesi
note
patient
exhibit
jaundic
hemorrhag
die
renal
failur
dissemin
intravascular
coagul
dic
accompani
elev
alt
ast
ldh
ddimer
decreas
platelet
count
group
rvf
patient
die
typic
hemorrhag
fever
also
enceph
addit
hepat
gastrointestin
necros
demonstr
neuroinvas
rvfv
hemorrhag
patient
anoth
type
fatal
case
rvfv
infect
describ
schwentker
et
al
report
temperatur
patient
fell
normal
day
onset
symptom
wherea
two
papular
area
sever
centimet
diamet
found
patient
thigh
leg
day
remain
day
tempor
recoveri
day
patient
experienc
phlebiti
poplit
vein
follow
infarct
lung
day
multipl
locat
eventu
caus
fatal
embolu
pulmonari
vessel
day
ill
liver
patient
normal
contain
infecti
rvfv
typic
rvf
lesion
confirm
postmortem
histopatholog
examin
howev
larg
thrombu
inferior
vena
cava
part
might
detach
caus
embolu
pulmonari
arteri
neutral
antibodi
show
day
ill
titer
increas
toward
day
retrospect
studi
egypt
increas
total
number
abort
seen
rvf
outbreak
serolog
convers
rate
abort
women
outbreak
respect
report
describ
potenti
vertic
infect
rvfv
concern
pregnant
woman
experienc
fever
headach
dizzi
gener
muscl
ach
four
day
deliveri
rvf
outbreak
saudi
arabia
develop
igg
specif
rvfv
newborn
babi
present
antirvfv
igm
antibodi
well
altast
elev
jaundic
extens
activ
partial
thromboplastin
time
aptt
test
defici
intrins
pathway
factor
prothrombin
time
pt
test
defici
extrins
pathway
factor
die
day
birth
although
unknown
whether
newborn
babi
die
rvf
possibl
vertic
transmiss
utero
might
occur
case
clinic
symptom
rvf
vari
among
patient
determin
host
suscept
induc
hemorrhag
fever
human
character
also
unknown
rvfv
caus
diseas
neurolog
disord
vision
loss
thrombosi
presenc
protect
antibodi
sever
anim
model
use
understand
patholog
rvf
advantag
disadvantag
differ
anim
model
summar
tabl
discuss
patholog
find
variou
differ
anim
model
next
chapter
mice
one
suscept
anim
speci
rvfv
infect
rvf
patholog
infect
mice
mimic
patholog
find
newborn
lamb
mice
infect
wildtyp
wt
rvfv
strain
die
day
wherea
die
faster
infect
wt
isol
infect
mice
show
ruf
fur
decreas
activ
day
becom
letharg
lie
back
leg
wide
apart
symptom
often
follow
death
within
one
hour
occasion
mice
surviv
stage
yet
hind
limb
paralysi
day
post
infect
pi
die
enceph
rectal
temperatur
infect
mice
often
normal
decreas
normal
also
clot
time
blood
deriv
rvfvinfect
mice
significantli
extend
clot
normal
mix
normal
sera
find
may
indic
shortag
coagul
factor
import
extens
clot
time
liver
major
target
organ
rvfv
enlarg
liver
common
liver
lesion
character
fulmin
hepat
coagul
necros
leav
portal
space
intact
deplet
glycogen
hepatocyt
also
common
earli
stage
infect
hepatocyt
mice
contain
eosinophil
intranuclear
inclus
bodi
reactiv
feulgen
reaction
nucleic
acid
stain
intranuclear
inclus
bodi
rvfvinfect
cultur
cell
visual
indirect
immunofluoresc
assay
antisera
rvfv
found
filamentari
shape
inclus
bodi
form
nss
protein
viral
nonstructur
protein
amino
acid
carboxyl
terminu
nss
respons
format
filament
structur
via
selfassoci
viral
antigen
start
accumul
hepatocyt
day
abund
increas
extens
day
pi
infect
hepatocyt
stain
use
termin
deoxynucleotidyl
transferas
dutp
nick
end
label
tunel
assay
indic
rvfv
replic
induc
apoptosi
hepatocyt
mice
surviv
earli
hepat
phase
often
abl
regener
hepatocyt
although
swollen
endotheli
cell
observ
liver
antigen
easili
detect
endotheli
cell
kuppfer
cell
indic
cell
primari
target
rvfv
addit
hepatocyt
viral
antigen
detect
odontogen
gingiv
epithelium
lipocyt
pituicyt
olfactori
neuron
multipl
type
neuron
brain
mononuclear
phagocyt
cardiac
myofib
perineur
periost
adrenocort
endost
perivascular
bone
marrow
stromal
fibroblast
reticular
vascular
smooth
muscl
cell
well
cell
morpholog
consist
dendrit
pancreat
islet
adren
medullari
cell
howev
viral
antigen
report
ocular
structur
includ
retina
apoptosi
lymphocyt
found
thymu
spleen
lymph
node
mucosaassoci
lymphoid
tissu
congest
hemorrhag
common
liver
spleen
lymph
node
larg
intestin
kidney
brain
uncommon
jejunum
mice
surviv
acut
viral
hepat
sharp
decreas
viral
antigen
occur
day
pi
viru
could
detect
sera
liver
lung
pancrea
larg
intestin
ovari
late
stage
infect
howev
lethal
meningoenceph
character
neuron
necrosi
microhemorrhag
perivascular
cuff
occur
mice
surviv
acut
hepat
suscept
rat
rvfv
differ
among
rat
strain
peter
et
al
demonstr
inbr
rat
us
breeder
exhibit
three
differ
respons
subcutan
sc
rvfv
inocul
wistarfurth
wf
brown
norway
strain
highli
suscept
rvfv
die
within
four
day
pi
liver
necrosi
fisher
buffalo
da
lewi
strain
larg
resist
rvfv
infect
aci
maax
strain
prove
moder
suscept
show
ascend
paralysi
lesion
mainli
brain
spinal
cord
character
mildtosever
necrot
enceph
encephalomyel
focal
necrosi
neutrophil
infiltr
perivascular
cuf
primarili
lymphocyt
aci
maax
strain
virus
undetect
liver
blood
wherea
log
pfug
virus
could
detect
brain
tissu
even
presenc
neutral
antibodi
serum
intracrani
inject
rvfv
uniformli
caus
enceph
rat
includ
resist
lewi
strain
immunosuppress
resist
lewi
rat
treat
anim
cyclophosphamid
day
prior
sc
rvfv
infect
result
death
around
day
pi
increas
viral
titer
serum
liver
spleen
brain
kidney
adren
gland
although
viru
titer
organ
lewi
rat
still
lower
correspond
organ
wf
strain
data
suggest
lewi
rat
encod
gene
import
resist
phenotyp
interestingli
wf
wfmol
lewi
rat
lewismol
obtain
european
breed
coloni
resist
suscept
rvfv
respect
henc
rat
show
opposit
suscept
rvfv
infect
strain
us
breeder
furthermor
wf
lewi
rat
obtain
anoth
european
breeder
resist
rvfv
infect
taken
togeth
find
indic
possibl
genet
variabl
inbr
rat
among
differ
breeder
crossbreed
experi
culmin
find
indic
resist
wfmol
rat
segreg
singl
mendelian
domin
locu
findlay
et
al
also
show
albino
rat
glaxo
strain
agedepend
suscept
rvfv
via
ip
rout
infect
rat
younger
day
die
day
extens
liver
necrosi
wherea
rat
surviv
rvfv
infect
syrian
hamster
one
suscept
rodent
rvfv
death
occur
day
pi
intraperiton
inocul
massiv
liver
necrosi
patholog
chang
similar
seen
mice
administr
low
titer
neutral
antibodi
protect
hamster
fatal
liver
necrosi
yet
infect
hamster
die
enceph
day
gerbil
merion
unguiculatu
repres
uniqu
rvfv
anim
model
produc
fatal
enceph
minim
liver
involv
infect
nonneuroadapt
wt
rvfv
gerbil
proven
moder
suscept
rvfv
surviv
rate
gerbil
sc
inocul
report
rang
depend
strain
inocul
dose
death
report
occur
around
week
doseindepend
manner
sc
inocul
pfu
result
surviv
outbr
tum
mon
gerbil
respect
surviv
inbr
montum
gerbil
respect
infect
gerbil
exhibit
hindlimb
paralysi
gener
weak
wast
gerbil
also
show
agedepend
resist
rvfv
infect
tum
mon
gerbil
die
pfu
sc
inocul
enceph
wherea
gerbil
abl
surviv
infect
sc
inocul
rvfv
replic
tempor
liver
gerbil
day
pfug
subsequ
effici
viru
replic
brain
occur
gerbil
day
day
pfug
gerbil
tempor
increas
day
intracerebr
wt
rvfv
inocul
pfu
gerbil
result
effici
viral
replic
pfug
brain
mean
time
death
six
day
statist
differ
gerbil
may
indic
presenc
host
factor
influenc
neuroinvas
agedepend
manner
histopatholog
minim
multifoc
necros
hepatocyt
seen
day
sc
inocul
wt
rvfv
focal
necrot
enceph
neuron
necrosi
neutrophil
infiltr
perivascular
cuf
seen
brain
later
time
point
mild
necrot
enceph
without
detect
infecti
rvfv
could
observ
even
clinic
normal
rvfinfect
gerbil
rhesu
macaqu
moder
suscept
rvfv
infect
ip
intranas
inocul
bodi
temperatur
infect
macaqu
increas
day
pi
febril
period
last
h
wherea
infect
anim
show
febril
reaction
peter
et
al
first
describ
hemorrhag
feverlik
ill
rhesu
macaqu
experiment
infect
wt
rvfv
strain
three
fifteen
rhesu
macaqu
intraven
inocul
rvfv
becam
ill
two
becam
moribund
euthan
day
one
recov
ill
wherea
other
show
tempor
viremia
maximum
viral
titer
occur
around
day
clinic
normal
three
monkey
exhibit
lassitud
weak
cessat
food
intak
petechia
ecchymos
bleed
nare
gum
venipunctur
site
clear
extens
aptt
slight
extens
pt
decreas
number
platelet
observ
two
dead
monkey
possibl
indic
defici
coagul
factor
platelet
histopatholog
dead
monkey
show
moder
focal
midzon
coagul
necrosi
liver
involv
approxim
hepatocyt
necrosi
ventricular
myocardium
fibrin
thrombi
glomeruli
small
intertubular
vessel
renal
medulla
kidney
mild
deplet
lymphocyt
white
pulp
deposit
eosinophil
amorph
fibrinlik
materi
red
pulp
cord
spleen
morril
et
al
report
intraven
inocul
pfu
strain
rhesu
macaqu
three
develop
sign
hemorrhag
fever
seven
clinic
ill
surviv
seven
surviv
without
clinic
sign
serum
interferon
ifn
detect
h
pi
h
pi
surviv
monkey
die
respect
delay
ifn
respons
preced
viremia
two
three
lethallyinfect
monkey
surviv
monkey
develop
sign
enceph
retin
complic
followup
observ
two
month
two
year
morril
et
al
also
demonstr
administr
recombin
leukocyt
ifn
u
im
h
rvfv
intraven
inocul
reduc
peak
viremia
titer
clear
virus
h
pi
studi
suggest
import
limit
viral
replic
findlay
et
al
report
three
speci
african
monkey
ie
green
guenon
cercopithecu
callitrichu
sooti
mangabey
cercocebu
fuliginosu
pata
guenon
erythrocebu
pata
exhibit
febril
reaction
inocul
rvfv
wherea
viru
detect
blood
contrast
four
speci
south
american
monkey
two
brown
capuchin
monkey
cebu
fatuellu
cebu
chrysopu
two
common
marmoset
callithrix
jacchu
callithrix
penicillata
exhibit
febril
reaction
day
upon
rvfv
infect
may
indic
south
american
monkey
suscept
rvfv
infect
african
monkey
davi
et
al
report
rvfvinfect
baboon
papio
anubi
viremia
day
without
develop
signific
clinic
sign
daubney
et
al
origin
report
outbreak
rvf
herd
sheep
kenya
character
high
rate
abort
pregnant
ewe
high
mortal
newborn
lamb
later
studi
easterday
et
al
describ
mortal
adult
sheep
follow
experiment
rvfv
infect
approxim
typic
sheep
one
week
old
rel
resist
rvfv
infect
yet
exhibit
fever
viremia
diarrhea
nasal
discharg
decreas
activ
nine
tenweekold
young
adult
sheep
ripollesa
breed
subcutan
inocul
rvfv
corneal
choroid
edema
inflammatori
infiltr
could
associ
drainag
failur
inadequ
corneal
dehydr
transient
viremia
hand
yansaka
sheep
subcutan
inocul
rvfv
die
virem
febril
phase
display
symptom
epistaxi
day
sever
bloodi
diarrhea
conjunctiv
hemorrhag
widespread
petechia
ecchymos
hairless
area
pulmonari
edemahemorrhag
thrombi
format
blood
vessel
heart
kidney
brain
rvfvinfect
west
african
dwarf
ouda
breed
exhibit
rapid
hemorrhag
symptom
rather
exhibit
mark
coagul
hepat
necrosi
brain
lesion
includ
mild
gliosi
neural
degener
neurophagia
satellitosi
interestingli
yansaka
west
african
dwarf
ouda
also
increas
prothrombin
time
may
indic
hemorrhag
induc
combin
vascular
endotheli
damag
inabl
clot
blood
respons
damag
inconsist
symptom
mortal
adult
sheep
describ
public
suggest
diverg
host
genet
background
even
within
breed
sheep
affect
suscept
rvfv
infect
sever
studi
examin
effect
rvfv
vaccin
candid
protect
pregnant
ewe
wt
rvfv
infect
howev
insuffici
immunogen
inactiv
vaccin
residu
virul
liveattenu
vaccin
induc
fetal
malform
pregnant
ewe
untreat
n
vaccin
n
formalininactiv
rvfv
challeng
wt
rvfv
day
post
vaccin
abort
occur
unvaccin
vaccin
ewe
day
pi
ewe
abort
fetus
one
vaccin
ewe
one
eight
unvaccin
ewe
die
data
may
indic
inactiv
rvfv
vaccin
induc
insuffici
immun
sheep
necropsi
day
pi
reveal
ewe
either
abort
dead
fetus
dead
abort
lamb
show
extens
liver
necrosi
typic
rvf
coetzer
et
al
report
immun
pregnant
ewe
liveattenu
smithburn
vaccin
strain
day
pregnanc
could
caus
teratogen
effect
fetu
includ
arthrogryposi
hydranencephali
miner
brain
without
hydrop
amnii
two
six
lamb
nine
vaccin
ewe
show
effect
hunter
et
al
describ
pregnant
ewe
inocul
liveattenu
vaccin
strain
day
gestat
either
miscarri
produc
lamb
show
teratogen
effect
lamb
vaccin
ewe
cerebellar
hypoplasia
spinal
hypoplasia
hydranencephali
prognathia
inferior
brachygnathia
inferior
arthrogryposi
scoiliosi
lordosi
kyphosi
dorm
head
abort
teratogen
effect
occur
pregnant
ewe
vaccin
third
trimest
pregnanc
ie
day
gestat
hand
pregnant
ewe
vaccin
day
gestat
rvfv
clone
strain
infram
delet
nss
caus
abort
fetal
malform
protect
wt
rvfv
challeng
data
may
impli
involv
nss
abort
ewe
teratogen
effect
lamb
rvfv
infect
caus
acut
fatal
diseas
newborn
lamb
rvfvinfect
newborn
lamb
usual
exhibit
obviou
ill
includ
elev
bodi
temperatur
loss
appetit
decreas
activ
prostrat
h
prior
death
mortal
rate
rvfvinfect
newborn
lamb
studi
experiment
infect
dayold
lamb
rvfv
via
sc
result
necrosi
isol
hepatocyt
h
pi
focal
coagul
necrosi
hepatocyt
h
pi
extens
hepatocyt
necrosi
h
pi
progress
increas
viral
antigen
wherea
viral
antigen
could
detect
endotheli
kupffer
cell
liver
suggest
hepatocyt
primari
target
rvfv
necrosi
predominantli
centrilobular
midzon
yet
definit
distribut
pattern
liver
necrosi
infect
lamb
also
exhibit
necrosi
villi
distal
jejunum
ileum
deplet
lymphocyt
spleen
wherea
brain
eye
lesion
overal
liver
patholog
newborn
lamb
resembl
mice
hamster
extrem
suscept
rvfv
howev
rvfv
neurovirul
lamb
less
promin
compar
rodent
rvfv
also
caus
diseas
anim
includ
goat
cattl
camel
dog
cat
ferret
caus
symptomat
diseas
rabbit
guinea
pig
bird
hors
pig
anim
review
detail
previous
present
mechan
speciesspecif
suscept
rvfv
infect
unknown
rvfv
infect
show
uniqu
pathogenesi
anim
model
viral
replic
host
antivir
respons
probabl
contribut
viral
pathogenec
understand
rvf
pathogenesi
requir
identif
character
viral
virul
factor
host
antivir
factor
next
chapter
describ
viral
determin
virul
rvfv
genom
compris
three
rna
segment
name
lsegment
figur
ssegment
encod
n
nss
gene
ambisens
manner
msegment
nsm
kd
gn
gc
gene
lsegment
rnadepend
rna
polymeras
l
gene
rvfv
virion
bind
unidentifi
cellular
receptor
enter
cell
phdepend
manner
probabl
clathrinmedi
endocyt
pathway
describ
anoth
phleboviru
viral
uncoat
viral
ribonucleocapsid
rnp
compos
viral
genom
rna
segment
n
protein
releas
cytoplasm
viral
polymeras
probabl
attach
rnp
exert
primari
transcript
synthes
viral
mrna
n
mrna
nss
mrna
transcrib
primari
transcript
earli
min
infect
effici
packag
viralsens
negativesens
ssegment
antiviralsens
positivesens
ssegment
respect
packag
mechan
rvfv
rnp
presenc
specif
cissign
genom
rna
known
viral
rna
replic
start
around
h
infect
increas
amount
viral
genom
rna
result
increas
viral
mrna
protein
rnp
packag
viral
virion
probabl
interact
cytoplasm
domain
gngc
golgi
apparatu
report
bunyavirus
three
differ
rna
segment
could
copackag
coordin
manner
copackag
ssegment
could
support
packag
lsegment
rvfv
virion
surfac
highli
symmetr
icosahedr
lattic
form
shell
glycoprotein
capsom
probabl
compos
gngc
heterodim
rvfv
msegment
encod
kd
nsm
gn
gc
protein
mrna
figur
protein
synthes
singl
open
read
frame
mrna
differ
aug
present
region
mrna
leaki
scan
ribosom
nterminu
gn
gc
cotransl
cleav
host
protein
nsm
synthes
aug
cterminu
gener
cleavag
nterminu
gn
kd
protein
synthes
aug
cterminu
ident
gn
among
seven
viral
protein
nss
nsm
nonstructur
protein
incorpor
virion
kd
protein
studi
detail
kd
protein
induc
rvfv
infect
probabl
correspond
current
kd
protein
known
incorpor
virion
may
indic
kd
protein
structur
protein
nss
kd
protein
nsm
dispens
viral
replic
cell
cultur
infect
femal
wf
rat
recombin
rvfv
strain
lack
kd
protein
nsm
induc
acut
fatal
hepat
diseas
caus
death
infect
rat
around
four
day
pi
delay
fatal
neurolog
diseas
result
death
infect
anim
around
day
pi
mortal
rate
wt
rat
develop
acut
hepat
die
data
suggest
nsm
essenti
virul
lethal
hand
recombin
rvfv
lack
express
kd
nsm
induc
extens
apoptosi
cultur
cell
express
nsm
significantli
inhibit
cleavag
induc
staurosporin
demonstr
nsm
protein
suppress
apoptosi
thu
nsm
probabl
suppress
apoptosi
infect
host
affect
viral
pathogen
nss
known
major
virul
factor
rvfv
rvfv
strain
infram
delet
nss
complet
attenu
mice
sheep
studi
show
nss
inhibit
synthesi
mrna
condit
transcript
factor
ifn
regulatori
factor
activ
protein
ap
activ
wt
rvfv
cell
found
nss
bind
sequest
subunit
tfiih
essenti
transcript
factor
rna
polymeras
ii
henc
nss
report
prevent
assembl
process
tfiih
complex
result
suppress
host
mrna
transcript
le
may
et
al
also
describ
studi
demonstr
region
nss
correspond
amino
acid
specif
bind
protein
form
complex
repress
histon
acetyl
requir
transcript
activ
promot
repress
work
even
bind
promot
henc
recombin
carri
delet
amino
acid
nss
suppress
mrna
synthesi
note
nss
bound
yet
suppress
express
although
inabl
nss
suppress
express
may
due
poor
accumul
infect
cell
studi
requir
know
bind
nss
lead
suppress
mrna
synthesi
also
uncertain
whether
gener
host
transcript
suppress
requir
inhibit
mrna
synthesi
nss
induc
host
gener
transcript
suppress
rvfv
might
abil
replic
host
transcript
suppress
actinomycin
actd
gener
inhibitor
host
rna
synthesi
viral
titer
sever
cytoplasm
rna
virus
includ
arenavirus
measl
viru
sindbi
viru
rubella
viru
polio
viru
coronavirus
lactic
dehydrogenas
elev
viru
could
reduc
presenc
actd
viral
rna
synthesi
often
unaffect
found
express
nss
protein
essenti
rvfv
strain
activ
synthes
viral
protein
produc
high
titer
infecti
virus
presenc
actd
cell
infect
recombin
rvfv
lack
nss
fail
synthes
viral
protein
cell
infect
lack
nss
accumul
phosphoryl
latter
made
cellular
translat
initi
inact
activ
dsrnadepend
protein
kinas
pkr
around
h
pi
result
suppress
viral
protein
synthesi
studi
reveal
nss
promot
degrad
pkr
proteasom
pathway
prevent
accumul
phosphoryl
therebi
secur
effici
viral
protein
synthesi
host
transcript
shutoff
induc
actd
habjan
et
al
report
wt
rvfv
nss
also
induc
pkr
degrad
demonstr
rvfv
strain
carri
biolog
inact
nss
induc
fatal
hepat
diseas
mice
lack
pkr
mice
compet
induc
typei
ifn
respons
viral
rna
replic
poli
poli
c
pkr
one
sever
ifnstimul
gene
isg
play
import
role
inhibit
viral
replic
vivo
rna
virus
includ
vesicular
stomat
viru
vsv
influenza
viru
also
replic
effici
mice
lack
pkr
intact
pkr
addit
pkr
ifninduc
mxa
protein
also
known
inhibit
rvfv
replic
although
genet
divers
rvfv
strain
rel
low
approxim
primari
sequenc
suscept
rat
differ
among
rvfv
strain
subsaharan
rvfv
strain
sensit
rat
unit
wherea
egyptian
strain
includ
zimbabwean
isol
rel
resist
rat
unit
rvfv
isol
show
similar
sensit
human
unit
summari
rvfv
nss
induc
shutdown
host
transcript
includ
transcript
typei
ifn
isg
mrna
prevent
antivir
respons
nss
also
induc
degrad
pkr
prevent
host
viral
translat
shutoff
promot
effici
viral
protein
synthesi
although
nss
major
virul
factor
escap
host
innat
immun
respons
virul
rvfv
could
control
polygen
manner
rvfv
strain
highli
attenu
strain
deriv
wt
rvfv
encod
function
nss
gene
mutat
lsegment
major
determin
attenu
contrast
strain
encod
ssegment
lack
function
nss
gene
lsegment
strain
still
virul
phenotyp
mice
lack
ifnar
mice
suscept
viral
replic
kinet
differ
mice
highest
titer
viremia
reach
within
h
pi
around
h
pi
mice
mice
respect
thu
possibl
lsegment
may
facilit
rapid
replic
mice
reach
highest
viru
titer
substanti
earlier
compar
mice
recent
found
wt
rvfv
viru
stock
contain
two
major
viral
popul
glu
gn
protein
gli
correspond
site
differ
amino
acid
map
within
one
neutral
epitop
gn
protein
although
known
two
differ
popul
emerg
viru
stock
amplifi
mous
brain
passag
twice
frhl
cell
twice
vero
cell
replic
less
effici
infect
mice
wherea
replic
effici
tissu
cultur
cell
studi
show
one
amino
acid
chang
gn
substanti
alter
replic
pathogenesi
vivo
yet
mechan
gn
mutat
pathogenesi
remain
unknown
clearli
studi
need
understand
role
viral
protein
rvfv
pathogenesi
rvfv
encod
sever
virul
factor
major
virul
factor
nss
play
import
role
evad
host
innat
immun
respons
next
chapter
discuss
human
host
anim
develop
protect
immun
respons
highli
virul
wt
rvfv
adequ
immun
rvfv
attenu
virul
rvfv
anim
vaccin
rvfv
save
anim
lethal
rvfv
challeng
passiv
transfer
neutral
antibodi
suffici
protect
lethal
rvf
wherea
role
cellular
immun
respons
protect
suffici
evalu
yet
mandel
et
al
demonstr
mice
immun
viruslik
particl
contain
n
higher
surviv
rate
surviv
contain
n
lethal
rvfv
challeng
surviv
antin
protein
antibodi
unlik
neutral
rvfv
data
may
point
involv
cellular
immun
respons
n
protein
rvfv
protect
altern
antivir
immun
respons
might
induc
form
complex
antin
antibodi
n
protein
releas
dead
cell
infect
cell
vivo
n
protein
present
cell
surfac
report
influenza
virusinfect
cell
complementmedi
cell
lysi
could
anoth
mechan
support
elimin
infect
cell
aerosol
exposur
one
like
rout
laboratori
infect
bioterror
attack
immun
rat
sc
inocul
formalininactiv
rvfv
vaccin
partial
protect
lethal
rvfv
aerosol
exposur
day
post
immun
surviv
wherea
surviv
rat
develop
enceph
without
clinic
sign
day
postchalleng
reveal
necropsi
anoth
studi
show
three
vaccin
rat
challeng
rvfv
aerosol
develop
uveiti
although
histopatholog
analysi
present
mice
highli
suscept
wt
rvfv
aerosol
exposur
pfu
may
caus
lethal
hepat
pneumonia
studi
mice
vaccin
sever
differ
rout
formalininactiv
rvfv
vaccin
challeng
rvfv
subcutan
show
immun
rout
affect
surviv
rate
sc
immun
intraperiton
ip
immun
intraduoden
id
immun
result
surviv
rate
less
respect
anoth
studi
report
fewer
mice
immun
via
sc
id
mice
immun
via
ip
surviv
aerosol
rout
challeng
rvfv
observ
period
find
studi
use
aerosol
rvfv
challeng
indic
mucos
immun
elicit
id
immun
success
lower
occurr
olfactori
bulb
enceph
fail
prevent
necrot
hepat
immun
induc
sc
id
prevent
hepat
olfactori
bulb
enceph
multifoc
enceph
ip
immun
complet
prevent
occurr
hepat
multifoc
enceph
report
seem
indic
immun
inactiv
vaccin
via
sc
prevent
rvfvinduc
diseas
aerosol
challeng
import
establish
reliabl
countermeasur
bioterror
use
rvfv
detail
character
rvfv
replic
variou
organ
aerosol
challeng
examin
efficaci
immun
current
liveattenu
rvfv
vaccin
candid
prevent
rvfinduc
diseas
rvfv
aerosol
challeng
exposur
anim
aerosol
contain
rvfv
probabl
result
initi
rvfv
infect
lung
epitheli
cell
type
alveolar
epitheli
cell
infect
releas
rvfv
occur
polar
epitheli
cell
cell
human
colorect
adenocarcinoma
cell
apic
basolater
membran
infect
punta
toro
viru
ptv
belong
phleboviru
genu
caus
lethal
necrot
hepat
hamster
mice
result
viru
releas
basolater
membran
may
contribut
system
viral
spread
infect
anim
describ
section
sever
studi
point
possibl
unidentifi
host
genet
factor
influenc
suscept
inbr
rat
speci
rvfv
primari
rat
hepatocyt
deriv
resist
american
lewi
rat
wfmol
rat
less
permiss
rvfv
infect
deriv
suscept
american
wf
rat
lewismol
rat
wherea
rvfv
replic
effici
primari
cortic
glial
cell
deriv
wfmol
rat
spontan
transform
cell
line
gener
embryon
thymu
cell
either
resist
lew
rat
suscept
wf
rat
suggest
hepatocyt
resist
inbr
rat
control
host
factor
restrict
effici
rvfv
replic
periton
macrophag
pm
deriv
resist
lewi
rat
suscept
wf
rat
treat
u
ifn
result
reduct
replic
lewi
pm
reduct
wf
pm
respect
possibl
indic
role
ifn
increas
resist
lewi
rat
hand
primari
hepatocyt
deriv
suscept
lewismol
rat
resist
wfmol
rat
resist
rvfv
treatment
cell
rat
typei
ifn
suggest
resist
induc
typei
ifn
necessarili
import
host
specif
resist
seen
wfmol
rat
recent
studi
show
mbtpa
mice
balbcbyi
mice
highli
suscept
rvfv
infect
experi
use
microarray
quantit
realtim
pcr
show
rvfv
replic
mous
embryon
fibroblast
mef
cell
deriv
suscept
mbtpa
mice
induc
higher
level
mrna
deriv
resist
balbcbyj
mice
mef
cell
deriv
mbtpa
mice
fail
induc
sever
isg
includ
ifn
regulatori
factor
mrna
oligoadenyl
synthetaselik
mrna
ifninduc
kda
protein
mrna
knockout
mrna
express
increas
viral
replic
mef
cell
deriv
resist
balbcbyj
mice
lead
author
suggest
mbtpa
mice
defect
ifn
respons
control
rvfv
spread
interest
know
whether
mice
lack
gene
suscept
rvfv
unknown
whether
suscept
inbr
rat
rvfv
due
deficit
isg
host
factor
determin
host
suscept
ptv
infect
explor
ptv
infect
mice
mimic
rvfvinduc
lethal
hepat
mice
show
agedepend
suscept
ptv
infect
mice
gradual
becom
resist
ptv
week
resist
eight
week
age
mice
show
delay
viremia
compar
mice
peak
viremia
titer
mice
lower
mice
likewis
ptv
replic
lower
primari
cultur
hepatocyt
kupffer
cell
peripher
blood
monocyt
isol
mice
cell
obtain
mice
ad
stress
mice
daili
handl
observ
increas
suscept
ptv
replic
role
tolllik
receptor
tlr
pathogen
recognit
receptor
recogn
doublestrand
rna
suscept
mice
ptv
studi
use
mice
background
wt
mice
infect
ptv
mortal
high
level
induct
yet
remark
increas
wherea
mice
lack
infect
ptv
increas
surviv
rate
slightli
earlier
reduct
serum
viru
titer
decreas
level
serum
hand
mice
suscept
ptv
infect
support
higher
level
viremia
wt
mice
possibl
mean
indispens
protect
immun
similar
attenu
virul
also
report
west
nile
viru
infect
mice
author
hypothes
overproduct
wt
mice
would
detriment
outcom
ptv
infect
point
balanc
cytokin
might
alter
pathogenesi
ptv
key
molecul
ifn
signal
pathway
report
ptv
replic
substanti
better
brain
mice
wt
mice
also
ptv
titer
sera
spleen
liver
mice
high
may
emphas
import
ifn
respons
limit
viral
replic
liver
spleen
brain
sinc
first
recognit
rvf
outbreak
year
pass
although
good
progress
character
clinic
patholog
virolog
featur
rvfv
infect
rvfv
still
caus
outbreak
african
countri
arabian
peninsula
develop
effect
safe
highli
immunogen
econom
vaccin
anim
human
prevent
rvf
endem
countri
sever
import
question
address
control
rvfv
understand
rvf
pathogenesi
includ
determin
mechan
trigger
hemorrhag
fever
rout
viral
entri
brain
mechan
prolong
diseas
rvf
patient
presenc
neutral
antibodi
signific
vaccin
prevent
rvf
aerosol
exposur
address
question
substanti
impact
understand
rvf
pathogenesi
develop
antirvfv
reagent
